鶹ýӰ

Impact Slides: MR CLEAN to SWIFT-PRIME With Patrick Lyden, MD

— Lyden reviews the 'field changing' results of endovascular stroke tx trials

MedpageToday

This article is a collaboration between MedPage Today and:

What are the key points from the recent spate of positive trials for mechanical thrombectomy for certain large-vessel ischemic strokes? , explores the significance of MR CLEAN, SWIFT-PRIME, and other randomized trials.

Lyden serves as chair of the department of neurology and director of the stroke program at Cedars-Sinai Medical Center in Los Angeles. He was an investigator on the key in the mid-1990s and remains on the editorial boards of Stroke, the International Journal of Stroke, and the Journal of Stroke and Cerebrovascular Disease.

From the American Heart Association: